MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, reported the voting results from its annual meeting of shareholders held today in a virtual-only setting.
Shareholders proceeded to elect the below candidates to the Company’s Board of Directors for a one-year term and appointed KPMG LLP as the Company’s auditors for the current fiscal year. All candidates proposed for the position of director were elected in the following proportion:
|
FOR
|
% FOR |
ABSTENTION
|
% ABSTENTION |
| Joseph Arena |
22,405,047 |
|
93.09 |
% |
1,663,754 |
|
6.91 |
% |
| Frank Holler |
21,008,601 |
|
87.29 |
% |
3,060,200 |
|
12.71 |
% |
| Paul Lévesque |
20,966,427 |
|
87.11 |
% |
3,102,374 |
|
12.89 |
% |
| Andrew Molson |
21,067,050 |
|
87.53 |
% |
3,001,751 |
|
12.47 |
% |
| Dawn Svoronos |
20,964,213 |
|
87.10 |
% |
3,104,588 |
|
2.90 |
% |
| Elina Tea |
21,734,254 |
|
90.30 |
% |
2,334,547 |
|
9.70 |
% |
| Dale Weil |
21,009,681 |
|
87.29 |
% |
3,059,120 |
|
12.71 |
% |
| Jordan Zwick |
23,107,383 |
|
96.01 |
% |
961,418 |
|
3.99 |
% |
Frank Holler will now act as Chair of the Board of Directors of the Company.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X (formerly Twitter).
Contacts:
Investor inquiries:
Philippe Dubuc
Senior Vice President and Chief Financial Officer
pdubuc@theratech.com
1-438-315-6608
Media inquiries:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
communications@theratech.com
1-514-336-7800
